Image-01-naloxone-structure (Image 01 Naloxone Structure)
Naloxone Hydrochloride Injection, Solution
Product Images NDC 43066-142
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 43066-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-02-figure (Image 02 Figure)
Image-03-figure-2a-2b (Image 03 Figure 2a 2b)
Image-04-figure-3 (Image 04 Figure 3)
Image-05-figure-4 (Image 05 Figure 4)
Image-06-syringe-label-2ml (Image 06 Syringe Label 2ml)
This is a description of a medication with the active ingredient Naloxone HCI in the form of an injection solution in a prefilled syringe. It is intended for intravenous, intramuscular, or subcutaneous use as an opioid antagonist. The single-use disposable syringe contains 1 mg/mL of the medication and should be discarded after use. The product should be protected from light and it is manufactured in India. The provided code for tracking is TG/MDL/2024-124903. The batch details and expiration date are also included in the text.*
Image-07-mono-carton-2ml (Image 07 Mono Carton 2ml)
This text provides detailed instructions for assembling and using a syringe containing Naloxone HCI Injection, USP. The syringe is prefilled and designed for Intravenous, Intramuscular, or Subcutaneous use as an Opioid Antagonist. It is essential to follow aseptic technique, ensure the syringe is securely attached to the needle or NLAD, and connect it appropriately based on the route of administration. The medication and fluid pathway are sterile and non-pyrogenic. Each mL of the solution contains 1 mg of naloxone hydrochloride and 8.35 mg of sodium chloride with a pH adjusted between 3.0 to 4. It is advised to store the syringe at 20° to 25°C (68° to 77°F) and protect it from light. Additional information on dosage, storage conditions, and manufacturer details are also included.*
Image-08-outer-carton-2ml (Image 08 Outer Carton 2ml)
This is a description of a batch of Naloxone HCI, which is an opioid antagonist used for intravenous, intramuscular, or subcutaneous use. The product comes in a 2 mL single-dose disposable prefilled syringe. It is important to discard any unused portion after use. The package does not include a needle. The usual dosage information is provided in the insert and it should be stored at a temperature between 20°C to 25°C, with excursions permitted between 15°C to 30°C. Users are advised to protect the product from light.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
